Evidence map›Paper›PMID 35368772›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2022

Association between NF-

Xiaoyi Shen, Sasa Tan, Xianzhen Feng, Wenzhen Fu, Yunqiu Hu, Miao Li, Wenjie Wang, Hu Yuan, Li Liu, Chun Wang and 1 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 60% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Xiaoyi ShenDepartment of Endocrinology, The Third Affiliated Hospital of Soochow University, 185, Juqian Street, Changzhou 213003, China.ORCID https://orcid.org/0000-0002-0225-6750
Sasa TanDepartment of General Practice, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, 111 Xianxia Road, Shanghai 200336, China.
Xianzhen FengDepartment of General Practice, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, 111 Xianxia Road, Shanghai 200336, China.
Wenzhen FuShanghai Clinical Research Center of Bone Disease, Department of Osteoporosis and Bone Disease, Affiliated Sixth People's Hospital, Shanghai Jiao Tong University, 600 Yishan Road, Shanghai 200233, China.
Yunqiu HuShanghai Clinical Research Center of Bone Disease, Department of Osteoporosis and Bone Disease, Affiliated Sixth People's Hospital, Shanghai Jiao Tong University, 600 Yishan Road, Shanghai 200233, China.
Miao LiShanghai Clinical Research Center of Bone Disease, Department of Osteoporosis and Bone Disease, Affiliated Sixth People's Hospital, Shanghai Jiao Tong University, 600 Yishan Road, Shanghai 200233, China.
Wenjie WangShanghai Clinical Research Center of Bone Disease, Department of Osteoporosis and Bone Disease, Affiliated Sixth People's Hospital, Shanghai Jiao Tong University, 600 Yishan Road, Shanghai 200233, China.
Hu YuanShanghai Clinical Research Center of Bone Disease, Department of Osteoporosis and Bone Disease, Affiliated Sixth People's Hospital, Shanghai Jiao Tong University, 600 Yishan Road, Shanghai 200233, China.
Li LiuShanghai Clinical Research Center of Bone Disease, Department of Osteoporosis and Bone Disease, Affiliated Sixth People's Hospital, Shanghai Jiao Tong University, 600 Yishan Road, Shanghai 200233, China.
Chun WangShanghai Clinical Research Center of Bone Disease, Department of Osteoporosis and Bone Disease, Affiliated Sixth People's Hospital, Shanghai Jiao Tong University, 600 Yishan Road, Shanghai 200233, China.ORCID https://orcid.org/0000-0003-4124-1575
Fei HuaDepartment of Endocrinology, The Third Affiliated Hospital of Soochow University, 185, Juqian Street, Changzhou 213003, China.ORCID https://orcid.org/0000-0001-6530-1582
Shanghai Jiao Tong University · CNSoochow University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Osteoporosis is a systemic bone disease characterized by reduction of bone content. Bisphosphonates are first-line treatments for osteoporosis, but they have variable effectiveness. Genetic factors may explain these differences. The NF- Methods: We recruited 455 postmenopausal Han Chinese women with primary osteoporosis or osteopenia aged 48-90 yrs who had experienced no spontaneous menses for at least 1 yr. All participants had dual X-ray absorptiometry (DEXA) bone mineral density (BMD) measurement at baseline and 1 yr after treatment. Treatment involved 1 yr administration of 70 mg oral alendronate weekly and 600 mg calcium and 125 IU of vitamin D daily. Thirteen tagSNPs in NF- Results: Among the 13 tagSNPs, rs289747 was significantly correlated with the BMD change rate at the femoral neck ( Conclusion: The NF

Identifiers

PMID35368772
PMCPMC8970858
OpenAlexW4220807361

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.